HMOX1 and hepatocellular carcinoma: Overexpression of HO-1 has been reported in lymphosarcoma (35), brain tumors (36), renal carcinoma (37), hepatoma (38), Kaposi sarcoma (39), pancreatic cancer (40) and chronic myeloid leukemia (41).